Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-01-19

FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Hydrochlorothiazide (generic) submitted by Teva Pharmaceuticals USA, Inc., under the ANDA program. The action confir…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

SUPPL AP for HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE)